Highly expression of TBC1D7 was related with poor outcome in non-small cell lung cancer (NSCLC), and suppression of TBC1D7 inhibits the growth of lung cancer cells, which might be a promising target in cancer therapy (12). Here, TBC1D7 is linked to cancer.